Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1957 1
1960 1
1965 1
1971 1
1972 2
1973 2
1975 1
1977 2
1979 2
1980 1
1981 2
1982 5
1983 2
1984 1
1985 15
1986 6
1987 10
1988 4
1989 12
1990 7
1991 12
1992 10
1993 19
1994 16
1995 13
1996 10
1997 10
1998 6
1999 18
2000 16
2001 14
2002 22
2003 14
2004 22
2005 26
2006 17
2007 23
2008 25
2009 20
2010 28
2011 33
2012 46
2013 24
2014 27
2015 33
2016 25
2017 24
2018 37
2019 36
2020 34
2021 14
Text availability
Article attribute
Article type
Publication date

Search Results

700 results
Results by year
Filters applied: . Clear all
Page 1
The Evolving Future of PCSK9 Inhibitors.
Rosenson RS, Hegele RA, Fazio S, Cannon CP. Rosenson RS, et al. Among authors: fazio s. J Am Coll Cardiol. 2018 Jul 17;72(3):314-329. doi: 10.1016/j.jacc.2018.04.054. Epub 2018 Jul 9. J Am Coll Cardiol. 2018. PMID: 30012326 Free article. Review.
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Borén J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgözoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL. Ference BA, et al. Among authors: fazio s. Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144. Eur Heart J. 2017. PMID: 28444290 Free PMC article. Review.
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
O'Donoghue ML, Fazio S, Giugliano RP, Stroes ESG, Kanevsky E, Gouni-Berthold I, Im K, Lira Pineda A, Wasserman SM, Češka R, Ezhov MV, Jukema JW, Jensen HK, Tokgözoğlu SL, Mach F, Huber K, Sever PS, Keech AC, Pedersen TR, Sabatine MS. O'Donoghue ML, et al. Among authors: fazio s. Circulation. 2019 Mar 19;139(12):1483-1492. doi: 10.1161/CIRCULATIONAHA.118.037184. Circulation. 2019. PMID: 30586750 Free article. Clinical Trial.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M. Jellinger PS, et al. Among authors: fazio s. Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL. Endocr Pract. 2017. PMID: 28437620
PCSK9: From Basic Science Discoveries to Clinical Trials.
Shapiro MD, Tavori H, Fazio S. Shapiro MD, et al. Among authors: fazio s. Circ Res. 2018 May 11;122(10):1420-1438. doi: 10.1161/CIRCRESAHA.118.311227. Circ Res. 2018. PMID: 29748367 Free PMC article. Review.
Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy.
Olazarán J, Reisberg B, Clare L, Cruz I, Peña-Casanova J, Del Ser T, Woods B, Beck C, Auer S, Lai C, Spector A, Fazio S, Bond J, Kivipelto M, Brodaty H, Rojo JM, Collins H, Teri L, Mittelman M, Orrell M, Feldman HH, Muñiz R. Olazarán J, et al. Among authors: fazio s. Dement Geriatr Cogn Disord. 2010;30(2):161-78. doi: 10.1159/000316119. Epub 2010 Sep 10. Dement Geriatr Cogn Disord. 2010. PMID: 20838046 Free article. Review.
700 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page